alt Hacker NewsA psychedelic medicine performs well against depression
Comments
What people get wrong is that you don't just trip balls and get cured. Re-integration therapy is vital for lasting effects. Grabbing some shrooms and digging in is recreation, which is perfectly fine, but don't fool yourself or anyone else by suggesting it's for treatment.
I believe there have been other studies that prove this for not just the synthetic. Yet we are all supposed to accept the "facts" that psilocybin (and cannabis) are considered schedule 1 illicit substances (high potential for abuse and no currently accepted medical use).
As someone who accidentally discovered the anti-depressive effects of psilocybin in my early 20s, I approve this message!
I know it will not "solve" every case of depression, however, I really wish people who don't already, would try going outside and/or exercising regularly.
Anecdotal I know, but it seems like nearly every person I know who does both are rarely if ever depressed.
While the people I've known who do struggle with depression rarely if ever leave home.
Again, I know this isn't a catch all for all cases, however, I've seen far too many people turn to meds/substances when lifestyle changes could be all that's required.
It's also a couple of things that only have positive side effects as opposed to most of the medicated approaches people take.
Does anyone know if it is just synthetic psilocybin or a psilocybin-like molecule?
Non-paywalled version here: https://qz.com/compass-pathways-psilocybin-fda-clinical-tria...
Looks like the paper hasn't been published yet, so there isn't really much detail, including blinding effectiveness (which is typically a problem for psychedelics).
The fact that they are using a synthetic version likely means they have constructed a molecule that’s patented or otherwise IP protected. I’m always torn about this, because it means that a cheap, globally available compound (psylocibin) which was what inspired this company to begin with when the founders used it on their son will remain medically inaccessible, possibly at Schedule I in the US, while this startup’s compound may end up being covered by insurance and rake in piles of cash.
I get that it takes a lot of money to prove the efficacy of drugs. But there should be a better way to open some of these chemicals up and acknowledge the community that has worked hard, often at great personal and reputational risk, to demonstrate that these well-known drugs offer powerful options to treat a range of psychiatric illnesses.